PT  - JOURNAL ARTICLE
AU  - Syed Usama Khalid Bukhari
AU  - Syed Safwan Khalid
AU  - Asmara Syed
AU  - Syed Sajid Hussain Shah
TI  - Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits
AID  - 10.1101/2020.04.21.20044594
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.21.20044594
4099  - http://medrxiv.org/content/early/2020/04/27/2020.04.21.20044594.short
4100  - http://medrxiv.org/content/early/2020/04/27/2020.04.21.20044594.full
AB  - There is an exponential growth of COVID-19. The adaptation of preventive measures to limit the spread of infection among the people is the best solution to this health issue. The identification of infected cases and their isolation from healthy people is one of the most important preventive measures. In this regard, screening of the samples from a large number of people is needed which requires a lot of reagent kits for the detection of SARS-CoV-2. The use of smart pooled sample testing with the help of algorithms may be a quite useful strategy in the current prevailing scenario of the COVID-19 pandemic. With the help of this strategy, the optimum number of samples to be pooled for a single test may be determined based on the total positivity rate of the particular community.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.worldometers.info/coronavirus/ https://www.worldometers.info/coronavirus/